OncoCyte Corp buy krebskrebs
Start price
15.11.21
/
50%
€2.58
Target price
15.11.22
€4.00
Performance (%)
-86.43%
End price
16.11.22
€0.35
Summary
This prediction ended on 16.11.22 with a price of €0.35. The BUY prediction by krebskrebs for OncoCyte Corp performed very badly with a performance of -86.43%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
OncoCyte Corp | - | - | - |
iShares Core DAX® | 2.749% | 4.620% | 17.121% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% |
Comments by krebskrebs for this prediction
In the thread OncoCyte Corp diskutieren
Buy mit Kursziel 4,0
In the thread Trading OncoCyte Corp
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten